Elis SA (LON:0RA8)
24.22
-0.36 (-1.46%)
At close: Nov 3, 2025
Elis SA Revenue
Elis SA had revenue of 2.34B EUR in the half year ending June 30, 2025, with 11.51% growth. This brings the company's revenue in the last twelve months to 4.67B, up 4.83% year-over-year. In the year 2024, Elis SA had annual revenue of 4.57B with 6.13% growth.
Revenue (ttm)
4.67B EUR
Revenue Growth
+4.83%
P/S Ratio
1.24
Revenue / Employee
82.28K EUR
Employees
56,757
Market Cap
4.96B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.57B | 264.30M | 6.13% |
| Dec 31, 2023 | 4.31B | 488.50M | 12.78% |
| Dec 31, 2022 | 3.82B | 772.60M | 25.35% |
| Dec 31, 2021 | 3.05B | 242.00M | 8.62% |
| Dec 31, 2020 | 2.81B | -475.50M | -14.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |